Compare ZLAB & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZLAB | PHIN |
|---|---|---|
| Founded | 2013 | 2023 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2017 | N/A |
| Metric | ZLAB | PHIN |
|---|---|---|
| Price | $18.34 | $61.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $57.22 | $57.20 |
| AVG Volume (30 Days) | ★ 937.7K | 406.0K |
| Earning Date | 11-06-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.18 |
| Revenue | $441,629,000.00 | ★ $3,427,000,000.00 |
| Revenue This Year | $26.16 | $3.03 |
| Revenue Next Year | $30.62 | $1.40 |
| P/E Ratio | ★ N/A | $28.07 |
| Revenue Growth | ★ 24.14 | N/A |
| 52 Week Low | $16.82 | $36.25 |
| 52 Week High | $44.34 | $61.86 |
| Indicator | ZLAB | PHIN |
|---|---|---|
| Relative Strength Index (RSI) | 40.35 | 79.37 |
| Support Level | $17.37 | $60.84 |
| Resistance Level | $19.01 | $61.86 |
| Average True Range (ATR) | 0.63 | 1.40 |
| MACD | 0.31 | 0.42 |
| Stochastic Oscillator | 57.51 | 97.78 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, the company generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.